The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Inflammatory Bowel Disease-Global Market Insights and Sales Trends 2024
Synopsis
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.
The global Inflammatory Bowel Disease market size is expected to reach US$ 16820 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Inflammatory Bowel Disease in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Inflammatory Bowel Disease market. Aminosalicylates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibiotics segment is estimated at % CAGR for the next seven-year period.
Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient's disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn's disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inflammatory Bowel Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inflammatory Bowel Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inflammatory Bowel Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inflammatory Bowel Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inflammatory Bowel Disease covered in this report include Bristol-Myers Squibb Company, Baxter International, Johnson & Johnson, Sanofi-Aventis, Abbott Laboratories, Pluristem Therapeutics, Pfizer, AstraZeneca and Cephalon, etc.
The global Inflammatory Bowel Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon
Amgen
Global Inflammatory Bowel Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inflammatory Bowel Disease market, Segment by Type:
Aminosalicylates
Antibiotics
Corticosteroids
Biologic therapies (biological drugs)
Others
Global Inflammatory Bowel Disease market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Inflammatory Bowel Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn's disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.
The global Inflammatory Bowel Disease market size is expected to reach US$ 16820 million by 2029, growing at a CAGR of 3.5% from 2023 to 2029. The market is mainly driven by the significant applications of Inflammatory Bowel Disease in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Inflammatory Bowel Disease market. Aminosalicylates, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibiotics segment is estimated at % CAGR for the next seven-year period.
Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient's disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn's disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Inflammatory Bowel Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Inflammatory Bowel Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Inflammatory Bowel Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Inflammatory Bowel Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Inflammatory Bowel Disease covered in this report include Bristol-Myers Squibb Company, Baxter International, Johnson & Johnson, Sanofi-Aventis, Abbott Laboratories, Pluristem Therapeutics, Pfizer, AstraZeneca and Cephalon, etc.
The global Inflammatory Bowel Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon
Amgen
Global Inflammatory Bowel Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Inflammatory Bowel Disease market, Segment by Type:
Aminosalicylates
Antibiotics
Corticosteroids
Biologic therapies (biological drugs)
Others
Global Inflammatory Bowel Disease market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Inflammatory Bowel Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Inflammatory Bowel Disease
1.1 Inflammatory Bowel Disease Market Overview
1.1.1 Inflammatory Bowel Disease Product Scope
1.1.2 Inflammatory Bowel Disease Market Status and Outlook
1.2 Global Inflammatory Bowel Disease Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Inflammatory Bowel Disease Market Size by Region (2018-2029)
1.4 Global Inflammatory Bowel Disease Historic Market Size by Region (2018-2023)
1.5 Global Inflammatory Bowel Disease Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Inflammatory Bowel Disease Market Size (2018-2029)
1.6.1 North America Inflammatory Bowel Disease Market Size (2018-2029)
1.6.2 Europe Inflammatory Bowel Disease Market Size (2018-2029)
1.6.3 Asia-Pacific Inflammatory Bowel Disease Market Size (2018-2029)
1.6.4 Latin America Inflammatory Bowel Disease Market Size (2018-2029)
1.6.5 Middle East & Africa Inflammatory Bowel Disease Market Size (2018-2029)
2 Inflammatory Bowel Disease Market by Type
2.1 Introduction
2.1.1 Aminosalicylates
2.1.2 Antibiotics
2.1.3 Corticosteroids
2.1.4 Biologic therapies (biological drugs)
2.1.5 Others
2.2 Global Inflammatory Bowel Disease Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Inflammatory Bowel Disease Historic Market Size by Type (2018-2023)
2.2.2 Global Inflammatory Bowel Disease Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Inflammatory Bowel Disease Revenue Breakdown by Type (2018-2029)
3 Inflammatory Bowel Disease Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Inflammatory Bowel Disease Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Inflammatory Bowel Disease Historic Market Size by Application (2018-2023)
3.2.2 Global Inflammatory Bowel Disease Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Inflammatory Bowel Disease Revenue Breakdown by Application (2018-2029)
4 Inflammatory Bowel Disease Competition Analysis by Players
4.1 Global Inflammatory Bowel Disease Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease as of 2022)
4.3 Date of Key Players Enter into Inflammatory Bowel Disease Market
4.4 Global Top Players Inflammatory Bowel Disease Headquarters and Area Served
4.5 Key Players Inflammatory Bowel Disease Product Solution and Service
4.6 Competitive Status
4.6.1 Inflammatory Bowel Disease Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bristol-Myers Squibb Company
5.1.1 Bristol-Myers Squibb Company Profile
5.1.2 Bristol-Myers Squibb Company Main Business
5.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Products, Services and Solutions
5.1.4 Bristol-Myers Squibb Company Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.1.5 Bristol-Myers Squibb Company Recent Developments
5.2 Baxter International
5.2.1 Baxter International Profile
5.2.2 Baxter International Main Business
5.2.3 Baxter International Inflammatory Bowel Disease Products, Services and Solutions
5.2.4 Baxter International Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.2.5 Baxter International Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Inflammatory Bowel Disease Products, Services and Solutions
5.3.4 Johnson & Johnson Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi-Aventis Recent Developments
5.4 Sanofi-Aventis
5.4.1 Sanofi-Aventis Profile
5.4.2 Sanofi-Aventis Main Business
5.4.3 Sanofi-Aventis Inflammatory Bowel Disease Products, Services and Solutions
5.4.4 Sanofi-Aventis Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi-Aventis Recent Developments
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Profile
5.5.2 Abbott Laboratories Main Business
5.5.3 Abbott Laboratories Inflammatory Bowel Disease Products, Services and Solutions
5.5.4 Abbott Laboratories Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Laboratories Recent Developments
5.6 Pluristem Therapeutics
5.6.1 Pluristem Therapeutics Profile
5.6.2 Pluristem Therapeutics Main Business
5.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Products, Services and Solutions
5.6.4 Pluristem Therapeutics Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.6.5 Pluristem Therapeutics Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer Inflammatory Bowel Disease Products, Services and Solutions
5.7.4 Pfizer Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 AstraZeneca
5.8.1 AstraZeneca Profile
5.8.2 AstraZeneca Main Business
5.8.3 AstraZeneca Inflammatory Bowel Disease Products, Services and Solutions
5.8.4 AstraZeneca Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.8.5 AstraZeneca Recent Developments
5.9 Cephalon
5.9.1 Cephalon Profile
5.9.2 Cephalon Main Business
5.9.3 Cephalon Inflammatory Bowel Disease Products, Services and Solutions
5.9.4 Cephalon Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.9.5 Cephalon Recent Developments
5.10 Amgen
5.10.1 Amgen Profile
5.10.2 Amgen Main Business
5.10.3 Amgen Inflammatory Bowel Disease Products, Services and Solutions
5.10.4 Amgen Inflammatory Bowel Disease Revenue (US$ Million) & (2018-2023)
5.10.5 Amgen Recent Developments
6 North America
6.1 North America Inflammatory Bowel Disease Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Inflammatory Bowel Disease Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Inflammatory Bowel Disease Market Dynamics
11.1 Inflammatory Bowel Disease Industry Trends
11.2 Inflammatory Bowel Disease Market Drivers
11.3 Inflammatory Bowel Disease Market Challenges
11.4 Inflammatory Bowel Disease Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
